JP2017512202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017512202A5 JP2017512202A5 JP2016554261A JP2016554261A JP2017512202A5 JP 2017512202 A5 JP2017512202 A5 JP 2017512202A5 JP 2016554261 A JP2016554261 A JP 2016554261A JP 2016554261 A JP2016554261 A JP 2016554261A JP 2017512202 A5 JP2017512202 A5 JP 2017512202A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sequence
- cholesterol
- nucleic acid
- immune response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461946372P | 2014-02-28 | 2014-02-28 | |
| US61/946,372 | 2014-02-28 | ||
| PCT/EP2015/054131 WO2015128461A1 (en) | 2014-02-28 | 2015-02-27 | Immunostimulatory plasmids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017512202A JP2017512202A (ja) | 2017-05-18 |
| JP2017512202A5 true JP2017512202A5 (enExample) | 2018-04-05 |
| JP6772065B2 JP6772065B2 (ja) | 2020-10-21 |
Family
ID=52598746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016554261A Expired - Fee Related JP6772065B2 (ja) | 2014-02-28 | 2015-02-27 | 免疫賦活プラスミド |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10155950B2 (enExample) |
| EP (1) | EP3110940A1 (enExample) |
| JP (1) | JP6772065B2 (enExample) |
| KR (1) | KR20160122849A (enExample) |
| CN (1) | CN106029867B (enExample) |
| AU (1) | AU2015222102B2 (enExample) |
| BR (1) | BR112016019837A2 (enExample) |
| CA (1) | CA2940794C (enExample) |
| CL (1) | CL2016002146A1 (enExample) |
| CR (1) | CR20160393A (enExample) |
| DO (1) | DOP2016000223A (enExample) |
| IL (1) | IL247065A0 (enExample) |
| MX (1) | MX2016010993A (enExample) |
| PE (1) | PE20170404A1 (enExample) |
| PH (1) | PH12016501705A1 (enExample) |
| RU (1) | RU2740492C2 (enExample) |
| SV (1) | SV2016005263A (enExample) |
| UA (1) | UA118374C2 (enExample) |
| WO (1) | WO2015128461A1 (enExample) |
| ZA (1) | ZA201605495B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160122849A (ko) * | 2014-02-28 | 2016-10-24 | 바이엘 애니멀 헬스 게엠베하 | 면역자극성 플라스미드 |
| ES2725948T3 (es) | 2014-06-04 | 2019-09-30 | Exicure Inc | Suministro multivalente de inmunomoduladores mediante ácidos nucleicos esféricos liposomales para aplicaciones profilácticas o terapéuticas |
| WO2016081911A2 (en) | 2014-11-21 | 2016-05-26 | Northwestern University | The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| JP2018518511A (ja) * | 2015-06-26 | 2018-07-12 | バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ | 細胞質ｄｎａ監視分子の調節方法 |
| CN108025062A (zh) * | 2015-07-31 | 2018-05-11 | 拜耳动物保健有限责任公司 | 猪科动物物种中增强的免疫应答 |
| WO2017021242A1 (en) * | 2015-07-31 | 2017-02-09 | Bayer Animal Health Gmbh | Enhanced immune response in aquatic species |
| WO2018022583A1 (en) * | 2016-07-26 | 2018-02-01 | Bayer Healthcare Llc | Increased fertility in bovine species |
| US11364304B2 (en) | 2016-08-25 | 2022-06-21 | Northwestern University | Crosslinked micellar spherical nucleic acids |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| WO2019115385A1 (en) * | 2017-12-15 | 2019-06-20 | Bayer Animal Health Gmbh | Immunostimulatory compositions |
| CN109646435B (zh) * | 2019-01-11 | 2021-08-03 | 山东省农业科学院奶牛研究中心 | 厄他培南钠在制备防治牛传染性鼻气管炎药物中的应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5427791A (en) | 1992-08-05 | 1995-06-27 | Regents Of The University Of Minnesota | Embryonal vaccine against Newcastle disease |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6645933B1 (en) * | 1995-08-01 | 2003-11-11 | Helsinki University Licensing Ltd. Oy | Receptor ligand VEGF-C |
| US5830878A (en) | 1995-06-07 | 1998-11-03 | Megabios Corporation | Cationic lipid: DNA complexes for gene targeting |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US6048535A (en) | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
| US6693086B1 (en) * | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US20040247662A1 (en) | 1998-06-25 | 2004-12-09 | Dow Steven W. | Systemic immune activation method using nucleic acid-lipid complexes |
| US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| CA2365416C (en) | 1999-03-26 | 2011-06-14 | Vical Incorporated | Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| US20040002472A1 (en) | 2000-01-21 | 2004-01-01 | Audonnet Jean-Christophe Francis | Vaccination or immunization using a prime-boost regimen |
| US6517218B2 (en) | 2000-03-31 | 2003-02-11 | Relume Corporation | LED integrated heat sink |
| PL366621A1 (en) * | 2001-04-24 | 2005-02-07 | Innogenetics N.V. | Core-glycosylated hcv envelope proteins |
| CA2452666A1 (en) | 2001-07-02 | 2003-01-16 | Pfizer Products Inc. | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| AU2002953015A0 (en) * | 2002-12-02 | 2002-12-12 | Women's And Children's Hospital | Modified lacz gene |
| MXPA05008526A (es) | 2003-03-26 | 2005-10-20 | Wyeth Corp | Metodos y composicion inmunogenica. |
| CA2542099A1 (en) | 2003-10-11 | 2005-04-21 | Inex Pharmaceuticals Corporation | Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| US20050181035A1 (en) | 2004-02-17 | 2005-08-18 | Dow Steven W. | Systemic immune activation method using non CpG nucleic acids |
| CA2577270A1 (en) * | 2004-08-13 | 2006-02-16 | The Trustees Of The University Of Pennsylvania | Antibiotic resistance free dna vaccines |
| UY29915A1 (es) | 2005-11-15 | 2007-06-29 | Boehringer Ingelheim Vetmed | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina |
| TWM297441U (en) | 2006-03-30 | 2006-09-11 | Cheng-Jiun Jian | LED projection light source module |
| US7663229B2 (en) | 2006-07-12 | 2010-02-16 | Hong Kong Applied Science And Technology Research Institute Co., Ltd. | Lighting device |
| RU2459631C2 (ru) * | 2006-10-06 | 2012-08-27 | Дзе Скриппс Рисерч Инститьют | Композиция днк для вызова иммунного ответа против опухолеассоциированных макрофагов |
| US8470560B2 (en) * | 2007-10-03 | 2013-06-25 | The United States Of America As Represented By The Secretary Of The Army | CR-2 binding peptide P28 as molecular adjuvant for DNA vaccines |
| JP5759890B2 (ja) | 2008-03-25 | 2015-08-05 | ジュバリス・バイオセラピューティクス・インコーポレイテッドＪｕｖａｒｉｓ Ｂｉｏｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | カチオン性脂質−ｄｎａ複合体（ｃｌｄｃ）の投与による免疫応答の増強 |
| MX2011004316A (es) | 2008-10-31 | 2011-06-16 | Boehringer Ingelheim Vetmed | Uso de antigenos diversos que incluyen antigenos de mycoplasma bovis en composicion de vacuna multivalente. |
| EP2992899B1 (en) | 2009-05-14 | 2020-07-01 | Bayer Intellectual Property GmbH | Enhanced immune response in avian species |
| HRP20190779T1 (hr) | 2010-12-22 | 2019-06-28 | Bayer Intellectual Property Gmbh | Pojačani imunosni odgovor kod goveda |
| CL2011000065A1 (es) | 2011-01-11 | 2011-04-15 | Univ Concepcion | Formulacion veterinaria para la prevencion y eliminacion de infeccion por cepas de e. coli stec, que comprende un plasmido recombinante que codifica un factor de virulencia y liposoma cationico como vehiculo, uso de dicha formulacion para tratar preferentemente bovinos y porcinos. |
| KR20160122849A (ko) * | 2014-02-28 | 2016-10-24 | 바이엘 애니멀 헬스 게엠베하 | 면역자극성 플라스미드 |
-
2015
- 2015-02-27 KR KR1020167026797A patent/KR20160122849A/ko not_active Withdrawn
- 2015-02-27 EP EP15707606.8A patent/EP3110940A1/en not_active Ceased
- 2015-02-27 US US14/633,920 patent/US10155950B2/en active Active
- 2015-02-27 CA CA2940794A patent/CA2940794C/en active Active
- 2015-02-27 AU AU2015222102A patent/AU2015222102B2/en not_active Ceased
- 2015-02-27 JP JP2016554261A patent/JP6772065B2/ja not_active Expired - Fee Related
- 2015-02-27 RU RU2016138321A patent/RU2740492C2/ru active
- 2015-02-27 BR BR112016019837A patent/BR112016019837A2/pt not_active Application Discontinuation
- 2015-02-27 MX MX2016010993A patent/MX2016010993A/es unknown
- 2015-02-27 PE PE2016001534A patent/PE20170404A1/es not_active Application Discontinuation
- 2015-02-27 CR CR20160393A patent/CR20160393A/es unknown
- 2015-02-27 CN CN201580010413.0A patent/CN106029867B/zh active Active
- 2015-02-27 UA UAA201609729A patent/UA118374C2/uk unknown
- 2015-02-27 WO PCT/EP2015/054131 patent/WO2015128461A1/en not_active Ceased
-
2016
- 2016-08-02 IL IL247065A patent/IL247065A0/en unknown
- 2016-08-08 ZA ZA2016/05495A patent/ZA201605495B/en unknown
- 2016-08-24 CL CL2016002146A patent/CL2016002146A1/es unknown
- 2016-08-26 DO DO2016000223A patent/DOP2016000223A/es unknown
- 2016-08-26 SV SV2016005263A patent/SV2016005263A/es unknown
- 2016-08-26 PH PH12016501705A patent/PH12016501705A1/en unknown
-
2018
- 2018-04-25 US US15/962,414 patent/US10851379B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017512202A5 (enExample) | ||
| RU2016138321A (ru) | Иммуностимулирующие плазмиды | |
| JP7523897B2 (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）ワクチン | |
| Schwendener | Liposomes as vaccine delivery systems: a review of the recent advances | |
| JP4294584B2 (ja) | 核酸ワクチン接種の免疫応答を高めるための方法 | |
| RU2013133730A (ru) | Повышение иммунного отклика у видов крупного рогатого скота | |
| JP2014522842A5 (enExample) | ||
| JP2014520807A5 (enExample) | ||
| CN101616687B (zh) | 非特异性免疫刺激剂 | |
| EP4153224A1 (en) | Coronavirus antigen compositions and their uses | |
| MXPA05013746A (es) | Conjugados de esfingoide-polialquilamina para vacunacion. | |
| EP4091630A1 (en) | Vaccines comprising r-dotap | |
| JP2023550600A (ja) | ｍＲＮＡワクチンを送達するための脂質ナノ粒子 | |
| Garulli et al. | Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo | |
| RU2014135522A (ru) | Промоторы для увеличенной экспрессии белка у менингококка | |
| JP2018518511A5 (enExample) | ||
| RU2018102915A (ru) | Способы модуляции контрольных молекул цитозольной днк | |
| US11111277B2 (en) | Influenza vaccines | |
| Lee et al. | Perspective of peptide vaccine composed of epitope peptide, CpG-DNA, and liposome complex without carriers | |
| AR105568A1 (es) | Un método para provocar una respuesta inmunitaria en un sujeto receptor de especie porcina | |
| Tomai et al. | TLR agonists as vaccine adjuvants | |
| EP3035960A2 (en) | Respiratory syncytial virus (rsv) vaccine | |
| US20240316178A1 (en) | Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof | |
| HK40083470A (en) | Vaccines comprising r-dotap | |
| WO2024131726A1 (zh) | 一种广谱流感mRNA疫苗 |